A systematic review and network meta-analysis of the comparative efficacy of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in hypertension-Reference-Cited by-同舟云学术

A systematic review and network meta-analysis of the comparative efficacy of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in hypertension

Published:2018-12-05 Issue:3 Volume:33 Page:188-201
ISSN:0950-9240
Container-title:Journal of Human Hypertension
language:en
Short-container-title:J Hum Hypertens

Author:

Dimou Chrisa,Antza Christina,Akrivos Evangelos,Doundoulakis Ioannis,Stabouli Stella,Haidich Anna Bettina,Kotsis Vasilios

Publisher

Springer Science and Business Media LLC

Subject

Internal Medicine

Link

http://www.nature.com/articles/s41371-018-0138-y.pdf

Reference59 articles.

1. World Health Organization, Regional Office for Europe. High blood pressure - country experiences and effective interventions utilized across the European Region. Copenhagen: WHO Regional Office for Europe; 2013.

2. Bommer WJ. Use of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker therapy to reduce cardiovascular events in high-risk patients: part 2. Prev Cardiol. 2008;11:215–22.

3. Heran BS, Wong MM, Heran IK, Wright JM. Blood pressure lowering efficacy of angiotensin converting enzyme (ACE) inhibitors for primary hypertension. Cochrane Database Syst Rev. 2008:CD003823.

4. Heran BS, Wong MM, Heran IK, Wright JM. Blood pressure lowering efficacy of angiotensin receptor blockers for primary hypertension. Cochrane Database Syst Rev. 2008:CD003822.

5. Li EC, Heran BS, Wright JM. Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension. Cochrane Database Syst Rev. 2014:CD009096.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel Insights in the Hypertension Treatment & Type 2 Diabetics Induced by Angiotensin Receptor Blockers: MD Simulation Studies & Molecular Docking of Some Promising Natural Therapies;ACS Omega;2024-05-02

2. Comparative Efficacy of Monotherapy of Angiotensin-converting Enzyme Inhibitors Versus Angiotensin Receptor Blockers in Treating Essential Hypertension – A Meta-analysis;Apollo Medicine;2024-04-29

3. Angiotensin‐converting enzyme inhibitor therapy after heart transplant: From molecular basis to clinical effects;Clinical Transplantation;2022-05-16

4. Hipertensión arterial esencial: ¿cuál agente antihipertensivo elegir?;Salud UIS;2022-04-06

5. The Number of Pills, Rather Than the Type of Renin–Angiotensin System Inhibitor, Predicts Ambulatory Blood Pressure Control in Essential Hypertensives on Triple Therapy: A Real-Life Cross-Sectional Study;Advances in Therapy;2021-06-11